Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Institutional

NeoNeuro SAS and AIBL group enter into a collaboration

Published on: 20/07/2017 Reading time: 1 min
Logo de NeoNeuro

NeoNeuro SAS and the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL) group are pleased to announce that they have entered into a collaboration to validate the performance of the Aptamarker platform for Alzheimer's disease diagnosis.

The Aptamarker platform is a global first in terms of enabling the characterization of millions of biomarkers simultaneously against a pathology in blood serum. Success with this project has the potential to provide new insights into subtypes of the disease by providing personalized characterization of individuals over time.

NeoNeuro is a French subsidiary of the Canadian aptamer company, NeoVentures Biotechnology Inc. The Aptamarker platform was developed by NeoNeuro with collaboration from the Institut du cerveau et de la moelle épinière (Institut du Cerveau - ICM) within the IPEPS incubator in Paris with financial support from the Banque Publique d'Investissement (BPI).

Our news on the subject

Visuel Voeux 2025
2025: An ambitious dynamic led by Prof. Stéphanie DEBETTE, the new Executive Director of the Institute since January 1, 2025
Professor Gérard SAILLANT, President of Paris Brain Institute, extends his warmest wishes to all those who, by faithfully supporting the research carried out at the institute, enable us to make a tangible difference in our fight against brain...
01.08.2025 Institutional
Stéphanie Debette
Professor Stéphanie Debette takes the helm of Paris Brain Institute
Appointed Executive Director of Paris Brain Institute for a five-year term, Professor Stéphanie Debette took up her new position on January 1, 2025. She succeeds Professor Alexis Brice, who has served as Executive Director since 2012.
01.07.2025 Institutional
L'IRM 7 Tesla à l’Institut du Cerveau
A 7-Tesla MRI scanner at Paris Brain Institute: cutting-edge technology at the service of scientific ambition
This week, Paris Brain Institute inaugurated an exceptional piece of equipment: the latest generation 7-Tesla MAGNETOM Terra.X MRI scanner from Siemens Healthineers. This acquisition, made possible thanks to the support of RICHARD MILLE and the...
11.28.2024 Institutional
Les participants du Dîner annuel de Paris Brain Institute America
Annual Dinner of Paris Brain Institute America at the French Consulate in New York – A Resounding Success for Neuroscience Research
On October 8, 2024, the French Consulate in New York hosted the annual dinner of Paris Brain Institute America (PBIA), gathering prominent philanthropists and influential figures from the scientific community for an evening dedicated to transatlantic...
10.15.2024 Support
erc
Nikolas Karalis, team leader at the Paris Brain Institute, is awarded the ERC Starting Grant 2024.
The European Research Council's (ERC) Starting Grants are prestigious and highly competitive awards, designed to enable young scientists to build their research team, and to carry out ambitious and innovative projects addressing unexplored scientific...
09.16.2024 Institutional
L'une des présentation lors de la visite
A special international visit: members and friends of the International Olympic Committee discover Paris Brain Institute
On Wednesday July 31, the Institute had the pleasure of welcoming a special group of visitors: members of the International Olympic Committee (IOC) and their friends and families.
09.08.2024 Institutional
See all our news